BioSpace News Archive

Drug Development

Tetra’s Alzheimer’s Drug Improves Language, Learning in Fragile X Syndrome

An investigational Alzheimer’s disease drug from Tetra Therapeutics appeared to improve language ability and learning in adults with Fragile X Syndrome, according to a new study reported in Nature Medicine.

April 30, 2021
·
2 min read
·
Brandon May
Job Trends

AstraZeneca Q1: Strong Growth with Some Pipeline Clean-up

AstraZeneca reported its first-quarter financial reports. As is often the case, they updated their pipeline, and indicated they had dropped a few drugs, including a promising multiple myeloma drug.

April 30, 2021
·
3 min read
·
Mark Terry
Policy

India’s Double Mutant Strain Raises Concern, But Companies Confident on Vaccine Effectiveness

A study found in India that the existing COVID-19 vaccines should be effective against the Indian variant, not just the Pfizer-BioNTech vaccine.

April 30, 2021
·
3 min read
·
Mark Terry
Policy

Bristol Myers’ Opdivo Fails to Maintain Accelerated Approval in Liver Cancer

The U.S. FDA’s Oncologic Drugs Advisory Committee did not agree in a recent meeting to maintain the accelerated approval of Bristol Myers Squibb’s Opdivo (nivolumab) as a second-line treatment of hepatocellular carcinoma.

April 30, 2021
·
3 min read
·
Brandon May
Drug Development

AstraZeneca Vaccine Collaborator Vaccitech Snares $110.5 Million IPO

After quietly filing plans for an initial public offering earlier this month, U.K.-based Vaccitech raised $110.5 million in its IPO.

April 30, 2021
·
2 min read
·
Alex Keown
FDA

FDA CRL Hurdle for LEO Pharma on Tralokinumab

The U.S. FDA has released a Complete Response Letter (CRL) following its review of LEO Pharma’s tralokinumab. Further data on a device component is the issue brought to light by the recently completed Biologics License Application (BLA) review.

April 30, 2021
·
2 min read
·
Ava Barnes
Policy

Cabenuva Approval and Updates: What You Need To Know

This drug is made and manufactured by ViiV Healthcare and is a combination of cabotegravir and rilpivirine.

April 30, 2021
·
4 min read
·
Lorenzo Soliman
Business

COVID-19 Vaccine Manufacturing Mishap Spurs C-Suite Shakeup at Emergent

Battered by vaccine manufacturing mishaps that led to the contamination of 15 million doses of the Johnson & Johnson vaccine, Emergent BioSolutions is shaking up its leadership to ensure such errors do not occur again.

April 30, 2021
·
3 min read
·
Alex Keown
Policy

AstraZeneca Hits Another Bump in the Road to COVID-19 Vaccine Approval in the US

AstraZeneca’s COVID-19 vaccine road to approval has been anything but smooth.

April 30, 2021
·
3 min read
·
Kate Goodwin
DEMO: Nanome Triggers Deep Drug Development Insights Via Virtual Molecule Design

If you equate virtual reality (VR) to games or pain relief applications, you’re missing one of science’s most amazing tools.

April 30, 2021
·
5 min read
·
Gail Dutton